MedAI Verdict
All comparisons

PERISCOPE vs Navina

Navina is built for primary care and value-based groups with attributed populations. It summarizes charts, recommends HCCs at the visit and lists care gaps, with athenahealth, Epic and Veradigm named on the homepage. KLAS comments say some deployments use a Chrome extension, and one director reports that the EHR vendor does not love that. A VP calls its risk adjustment very good but focused on Medicare. Pricing is quote-only.

PERISCOPE is for a hospital's surgical quality team and follows post-operative patients, which puts it outside Navina's attributed primary care populations. It predicts postoperative bacterial infection from existing EHR data with XGBoost models built per hospital, and the vendor puts implementation at 8 to 12 weeks depending on the EHR. Testimonials come from Deventer Ziekenhuis and Amsterdam UMC.

Decision support · Reviewed November 2, 2026

PERISCOPE logo

PERISCOPE

by Healthplus.ai

PERISCOPE predicts postoperative bacterial infection risk 7 and 30 days after surgery from EHR data.

Navina logo

Navina

by Navina · founded 2018

AI copilot for chart review, risk adjustment and care gaps in primary care and value-based care groups.

When to pick each one

PERISCOPE

  • Per-hospital XGBoost infection prediction from EHR data
  • Implementation 8 to 12 weeks, vendor says
Read the full PERISCOPE review

Navina

  • Chart summaries and care-gap closure for value-based groups
  • HIPAA, SOC 2 and ISO 27001 badges
Read the full Navina review

Score

Each row shows points earned of points available under the published rubric.

PERISCOPE

15of 100

Tracked

Navina

36of 100

Competitive
Score by dimension for PERISCOPE and Navina
DimensionPERISCOPENavinaDifference
FDA clearance0 / 120 / 120
HIPAA / SOC2 / BAA0 / 1010 / 10-10
EHR integrations (count)0 / 5.61.7 / 5.6-1.7
Top-3 EHR coverage (Epic / Oracle / Athena)0 / 4.83.4 / 4.8-3.4
Bidirectional write-back0 / 1.20 / 1.20
Peer-reviewed papers8.4 / 210 / 21+8.4
RCT / meta-analysis / systematic review0 / 90 / 90
Funding & adoption signal3 / 128.4 / 12-5.4
Pricing transparency1.3 / 2.51.3 / 2.50
Years in market0 / 66 / 6-6

Scroll horizontally to see every column.

How scores are computed

Pricing

PERISCOPE

TierMonthlyAnnualNotes
Enterprisen/an/aNo public price.

Navina

TierMonthlyAnnualNotes
Enterprisen/an/aNo public price.

Evidence

Navina

FDA decisions

No FDA decision cited in our research as of November 2, 2026.

Compliance and integrations

Documented from each vendor’s own pages.

SpecPERISCOPENavina
Free tierNo / unverifiedNo / unverified
HIPAANo / unverifiedYes
SOC 2 Type IINo / unverifiedYes
EHR integrationsNot specifiedathenahealth, Epic, Veradigm
Foundedn/a2018
HQNLn/a

Scroll horizontally to see both columns.

Common questions

Open the full decision support comparison

Differential diagnosis, treatment guidance, drug interactions, evidence-grounded Q&A. The CDS landscape ranges from the UpToDate gold standard to physician-only OpenEvidence. We compared what clinicians actually use.